Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents

Aim We aimed to assess the influence of fasting insulin resistance on metabolically healthy obesity (MHO) prevalence in adolescents and to identify associated factors. Methods This retrospective, registry‐based, cross‐sectional study included 418 (51.9% girls) 10‐ to 18‐year‐old adolescents with obe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Paediatrica 2019-07, Vol.108 (7), p.1295-1302
Hauptverfasser: Marra, Nivea Fazanaro, Bechere Fernandes, Maria Teresa, Melo, Maria Edna, Cruz, Rodrigo Marques, Tess, Beatriz Helena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1302
container_issue 7
container_start_page 1295
container_title Acta Paediatrica
container_volume 108
creator Marra, Nivea Fazanaro
Bechere Fernandes, Maria Teresa
Melo, Maria Edna
Cruz, Rodrigo Marques
Tess, Beatriz Helena
description Aim We aimed to assess the influence of fasting insulin resistance on metabolically healthy obesity (MHO) prevalence in adolescents and to identify associated factors. Methods This retrospective, registry‐based, cross‐sectional study included 418 (51.9% girls) 10‐ to 18‐year‐old adolescents with obesity from a tertiary outpatient clinic in Sao Paulo, Brazil, between 2009 and 2013. The prevalence of MHO was estimated according to two definitions: (i) no cardiometabolic risk factors (CMRF) by the International Diabetes Federation parameters and (ii) no CMRF and homeostatic model assessment for insulin resistance
doi_str_mv 10.1111/apa.14684
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2155165572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242538881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3534-70769b6aad5f4e4e59e5109a5ec273dade1e2b8259067223e4220c78a937a8353</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EokvhwAsgS1zoIa09thPnuK0oIFWCA5ytSTJhXbzJYjug8PR12cIBiblYGn3-NPp_xl5KcS7LXOABz6WurX7ENrI2sgKA5jHbCCtUZcCoE_YspVshQLW6fspOlDCqtqA37Ns1puynr9xPaQl-4pGSTxmnnjiOI_U58bwjfoj0AwPdr-eR7yljNwffYwgr3xGGvFv53JW_eS0qfhnxlw8eJ47DHCj1NOX0nD0ZMSR68fCesi_Xbz9fva9uPr77cLW9qXpllK4a0dRtVyMOZtSkybRkpGjRUA-NGnAgSdBZMK2oGwBFGkD0jcVWNWiL4pS9OXoPcf6-UMpu78sFIeBE85IcSGNKTKaBgr7-B72dlziV6xyALslZa2Whzo5UH-eUIo3uEP0e4-qkcPcNuNKA-91AYV89GJduT8Nf8k_kBbg4Aj99oPX_Jrf9tD0q7wCbxo_i</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242538881</pqid></control><display><type>article</type><title>Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents</title><source>Access via Wiley Online Library</source><source>Alma/SFX Local Collection</source><creator>Marra, Nivea Fazanaro ; Bechere Fernandes, Maria Teresa ; Melo, Maria Edna ; Cruz, Rodrigo Marques ; Tess, Beatriz Helena</creator><creatorcontrib>Marra, Nivea Fazanaro ; Bechere Fernandes, Maria Teresa ; Melo, Maria Edna ; Cruz, Rodrigo Marques ; Tess, Beatriz Helena</creatorcontrib><description>Aim We aimed to assess the influence of fasting insulin resistance on metabolically healthy obesity (MHO) prevalence in adolescents and to identify associated factors. Methods This retrospective, registry‐based, cross‐sectional study included 418 (51.9% girls) 10‐ to 18‐year‐old adolescents with obesity from a tertiary outpatient clinic in Sao Paulo, Brazil, between 2009 and 2013. The prevalence of MHO was estimated according to two definitions: (i) no cardiometabolic risk factors (CMRF) by the International Diabetes Federation parameters and (ii) no CMRF and homeostatic model assessment for insulin resistance &lt;3.16. Adjusted prevalence ratios and 95% confidence intervals (CI) evaluated the association of gender, age, pubertal stages, skin colour and degree of obesity with MHO. Results Metabolically healthy obesity prevalence was lower in definition II than definition I (12.7%; 95% CI 9.1–16.3% versus 43.1%; 95% CI 38.0–48.2%, respectively). Adjusted results showed negative association between severe obesity and MHO by both definitions (p ≤ 0.01). Male and later pubertal stages were also less likely to have MHO, but neither remained significant in definition II. Conclusion Metabolically healthy obesity prevalence decreased when insulin resistance was part of the definition. Detecting pre‐clinical insulin resistance may improve the management of treatment‐seeking adolescents, especially when they present no CMRF.</description><identifier>ISSN: 0803-5253</identifier><identifier>EISSN: 1651-2227</identifier><identifier>DOI: 10.1111/apa.14684</identifier><identifier>PMID: 30536824</identifier><language>eng</language><publisher>Norway: Wiley Subscription Services, Inc</publisher><subject>Adolescents ; Brazil ; Diabetes mellitus ; Fasting ; Health risks ; Insulin ; Insulin resistance ; Metabolically healthy obesity ; Obesity ; Prevalence ; Risk factors ; Skin ; Teenagers</subject><ispartof>Acta Paediatrica, 2019-07, Vol.108 (7), p.1295-1302</ispartof><rights>2018 Foundation Acta Pædiatrica. Published by John Wiley &amp; Sons Ltd</rights><rights>2018 Foundation Acta Paediatrica. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright ©2019 Foundation Acta Pædiatrica</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3534-70769b6aad5f4e4e59e5109a5ec273dade1e2b8259067223e4220c78a937a8353</citedby><cites>FETCH-LOGICAL-c3534-70769b6aad5f4e4e59e5109a5ec273dade1e2b8259067223e4220c78a937a8353</cites><orcidid>0000-0002-9921-9234 ; 0000-0002-9819-4573</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapa.14684$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapa.14684$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30536824$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marra, Nivea Fazanaro</creatorcontrib><creatorcontrib>Bechere Fernandes, Maria Teresa</creatorcontrib><creatorcontrib>Melo, Maria Edna</creatorcontrib><creatorcontrib>Cruz, Rodrigo Marques</creatorcontrib><creatorcontrib>Tess, Beatriz Helena</creatorcontrib><title>Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents</title><title>Acta Paediatrica</title><addtitle>Acta Paediatr</addtitle><description>Aim We aimed to assess the influence of fasting insulin resistance on metabolically healthy obesity (MHO) prevalence in adolescents and to identify associated factors. Methods This retrospective, registry‐based, cross‐sectional study included 418 (51.9% girls) 10‐ to 18‐year‐old adolescents with obesity from a tertiary outpatient clinic in Sao Paulo, Brazil, between 2009 and 2013. The prevalence of MHO was estimated according to two definitions: (i) no cardiometabolic risk factors (CMRF) by the International Diabetes Federation parameters and (ii) no CMRF and homeostatic model assessment for insulin resistance &lt;3.16. Adjusted prevalence ratios and 95% confidence intervals (CI) evaluated the association of gender, age, pubertal stages, skin colour and degree of obesity with MHO. Results Metabolically healthy obesity prevalence was lower in definition II than definition I (12.7%; 95% CI 9.1–16.3% versus 43.1%; 95% CI 38.0–48.2%, respectively). Adjusted results showed negative association between severe obesity and MHO by both definitions (p ≤ 0.01). Male and later pubertal stages were also less likely to have MHO, but neither remained significant in definition II. Conclusion Metabolically healthy obesity prevalence decreased when insulin resistance was part of the definition. Detecting pre‐clinical insulin resistance may improve the management of treatment‐seeking adolescents, especially when they present no CMRF.</description><subject>Adolescents</subject><subject>Brazil</subject><subject>Diabetes mellitus</subject><subject>Fasting</subject><subject>Health risks</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Metabolically healthy obesity</subject><subject>Obesity</subject><subject>Prevalence</subject><subject>Risk factors</subject><subject>Skin</subject><subject>Teenagers</subject><issn>0803-5253</issn><issn>1651-2227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EokvhwAsgS1zoIa09thPnuK0oIFWCA5ytSTJhXbzJYjug8PR12cIBiblYGn3-NPp_xl5KcS7LXOABz6WurX7ENrI2sgKA5jHbCCtUZcCoE_YspVshQLW6fspOlDCqtqA37Ns1puynr9xPaQl-4pGSTxmnnjiOI_U58bwjfoj0AwPdr-eR7yljNwffYwgr3xGGvFv53JW_eS0qfhnxlw8eJ47DHCj1NOX0nD0ZMSR68fCesi_Xbz9fva9uPr77cLW9qXpllK4a0dRtVyMOZtSkybRkpGjRUA-NGnAgSdBZMK2oGwBFGkD0jcVWNWiL4pS9OXoPcf6-UMpu78sFIeBE85IcSGNKTKaBgr7-B72dlziV6xyALslZa2Whzo5UH-eUIo3uEP0e4-qkcPcNuNKA-91AYV89GJduT8Nf8k_kBbg4Aj99oPX_Jrf9tD0q7wCbxo_i</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Marra, Nivea Fazanaro</creator><creator>Bechere Fernandes, Maria Teresa</creator><creator>Melo, Maria Edna</creator><creator>Cruz, Rodrigo Marques</creator><creator>Tess, Beatriz Helena</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9921-9234</orcidid><orcidid>https://orcid.org/0000-0002-9819-4573</orcidid></search><sort><creationdate>201907</creationdate><title>Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents</title><author>Marra, Nivea Fazanaro ; Bechere Fernandes, Maria Teresa ; Melo, Maria Edna ; Cruz, Rodrigo Marques ; Tess, Beatriz Helena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3534-70769b6aad5f4e4e59e5109a5ec273dade1e2b8259067223e4220c78a937a8353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescents</topic><topic>Brazil</topic><topic>Diabetes mellitus</topic><topic>Fasting</topic><topic>Health risks</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Metabolically healthy obesity</topic><topic>Obesity</topic><topic>Prevalence</topic><topic>Risk factors</topic><topic>Skin</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marra, Nivea Fazanaro</creatorcontrib><creatorcontrib>Bechere Fernandes, Maria Teresa</creatorcontrib><creatorcontrib>Melo, Maria Edna</creatorcontrib><creatorcontrib>Cruz, Rodrigo Marques</creatorcontrib><creatorcontrib>Tess, Beatriz Helena</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Acta Paediatrica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marra, Nivea Fazanaro</au><au>Bechere Fernandes, Maria Teresa</au><au>Melo, Maria Edna</au><au>Cruz, Rodrigo Marques</au><au>Tess, Beatriz Helena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents</atitle><jtitle>Acta Paediatrica</jtitle><addtitle>Acta Paediatr</addtitle><date>2019-07</date><risdate>2019</risdate><volume>108</volume><issue>7</issue><spage>1295</spage><epage>1302</epage><pages>1295-1302</pages><issn>0803-5253</issn><eissn>1651-2227</eissn><abstract>Aim We aimed to assess the influence of fasting insulin resistance on metabolically healthy obesity (MHO) prevalence in adolescents and to identify associated factors. Methods This retrospective, registry‐based, cross‐sectional study included 418 (51.9% girls) 10‐ to 18‐year‐old adolescents with obesity from a tertiary outpatient clinic in Sao Paulo, Brazil, between 2009 and 2013. The prevalence of MHO was estimated according to two definitions: (i) no cardiometabolic risk factors (CMRF) by the International Diabetes Federation parameters and (ii) no CMRF and homeostatic model assessment for insulin resistance &lt;3.16. Adjusted prevalence ratios and 95% confidence intervals (CI) evaluated the association of gender, age, pubertal stages, skin colour and degree of obesity with MHO. Results Metabolically healthy obesity prevalence was lower in definition II than definition I (12.7%; 95% CI 9.1–16.3% versus 43.1%; 95% CI 38.0–48.2%, respectively). Adjusted results showed negative association between severe obesity and MHO by both definitions (p ≤ 0.01). Male and later pubertal stages were also less likely to have MHO, but neither remained significant in definition II. Conclusion Metabolically healthy obesity prevalence decreased when insulin resistance was part of the definition. Detecting pre‐clinical insulin resistance may improve the management of treatment‐seeking adolescents, especially when they present no CMRF.</abstract><cop>Norway</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30536824</pmid><doi>10.1111/apa.14684</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9921-9234</orcidid><orcidid>https://orcid.org/0000-0002-9819-4573</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0803-5253
ispartof Acta Paediatrica, 2019-07, Vol.108 (7), p.1295-1302
issn 0803-5253
1651-2227
language eng
recordid cdi_proquest_miscellaneous_2155165572
source Access via Wiley Online Library; Alma/SFX Local Collection
subjects Adolescents
Brazil
Diabetes mellitus
Fasting
Health risks
Insulin
Insulin resistance
Metabolically healthy obesity
Obesity
Prevalence
Risk factors
Skin
Teenagers
title Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T04%3A59%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fasting%20insulin%20resistance%20affects%20the%20prevalence%20of%20metabolically%20healthy%20obesity%20in%20Brazilian%20adolescents&rft.jtitle=Acta%20Paediatrica&rft.au=Marra,%20Nivea%20Fazanaro&rft.date=2019-07&rft.volume=108&rft.issue=7&rft.spage=1295&rft.epage=1302&rft.pages=1295-1302&rft.issn=0803-5253&rft.eissn=1651-2227&rft_id=info:doi/10.1111/apa.14684&rft_dat=%3Cproquest_cross%3E2242538881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242538881&rft_id=info:pmid/30536824&rfr_iscdi=true